CL
ClearPoint Neuro, Inc.
CLPT · NASDAQ
$13.72 +0.51% (+$0.07)
1M -11.02%
Market Cap $404.3M
P/E Ratio -
Div. Yield -
ROE 188.09%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 37.51x
P/S 9.56x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 8.76%
Rev. growth 21.62%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 73.42%
Gross margin 62.61%
FCF margin 74.01%
Quality
6 /100
Poor ROA 39.85%
ROIC 40.49%
Asset turnover 0.49x
Debt
23 /100
High Int. coverage -7.63x
Debt/Equity 5.93x
Current ratio 4.73x
Stability
64 /100
Moderate EPS volatility 30.48%
Beta 1.27x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CLPT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Michael Burnett
Employees
172
Headquarters
Solana Beach
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report